(Q37687748)
Statements
1 reference
The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability? (English)
1 reference
Martin C Michel
1 reference
4 February 2010
1 reference
1 reference
112
1 reference
2
1 reference
151-157
1 reference
Identifiers
1 reference
1 reference